{"a":[{"_":"Novo CEO sees advantages in souping up NYSE listing: report","$":{"href":"/pharma/doustdar-says-novo-open-upgrading-its-nyse-listing","hreflang":"en"}}]}

OzempicWegovyNeutral

AI Analysis

Novo Nordisk's CEO indicated openness to pursuing a direct listing on the New York Stock Exchange, though no transition is currently planned.

Importance:3/10

Sentiment:

0.00

listingNYSEcorporate structuredirect listing

Related Companies

Read the original article

Published by FiercePharma on September 23, 2026 10:55 AM